MAP2K7 and malignant colon neoplasm: Consistently, the colon cancer cells has been found to utilize similar pathway as myoblasts through which MEK inhibition activates Mirk/Dyrk1B promoter constructs and increases Mirk/Dyrk1B transcription [2].